How many studies have been conducted on Ctla 4 Antigen?

BiohacksAI has indexed 97 PubMed studies on Ctla 4 Antigen, including 3 randomized controlled trials (RCTs). 73% of studies involve human subjects.

What are the main research areas for Ctla 4 Antigen?

The primary research domains for Ctla 4 Antigen are 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney. This is based on analysis of 97 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Ctla 4 Antigen

An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. CTLA-4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.

97+ PubMed studies analyzed · 3 RCTs · Evidence Score: 51.1

Research Domains

Ctla 4 Antigen has been studied across 18 research domains including 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney, 🔬 Inflammation, ⏳ Longevity & Aging. The primary research focus is 🔬 Oncology with 73% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ctla 4 Antigen is generated deterministically from 97 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.